Diabetes

When a patient begins using insulin to manage diabetes, the initial dose is just a starting point.

Obese patients typically require higher doses of insulin therapy.

Study evaluates the association between consuming butter and the development of diabetes and other chronic diseases.

The FDA has approved an expanded indication for type 2 diabetes treatment Synjardy (empagliflozin and metformin hydrochloride) to include treatment-naïve adults. Synjardy is designed to improve glycemic control in adults with type 2 diabetes.

Synjardy expanded to include treatment naïve adults with type 2 diabetes.

Surveys show patients more willing to seek more aggressive treatment than physicians realize.

The Diabetes Prevention Program is the first prevention program to expand from CMS Innovation Center to Medicare.

Surprising findings on the relationship between obesity, type 2 diabetes, and dementia.

Top news of the day from across the health care landscape.

In addition to weight gain and poor diet quality, eating meals outside the home has been linked with a greater risk of developing type 2 diabetes.

Benign meningioma tumors may be less likely in patients with high blood sugar.

More than 30 national health care decision-makers have gathered outside of the Nation's Capital this week for an Academy of Managed Care Pharmacy event focusing on innovations in diabetes care that are producing changes to treatment options, patient engagement, accountability and patient-provider interactions.

Liraglutide found to lower the overall risk of stroke and heart attack.

Although longer needles are often prescribed for patients with increased body fat, this practice actually has no clinical basis.

Regular physical activity is effective lowering the risk of diabetes, but some patients do not see improved insulin sensitivity.

The FDA has approved a dedicated syringe for Humulin R U-500 insulin, eliminating the need for dose conversions for patients who previously used U-100 tuberculin syringes.

Women averaging 60-hour work weeks found to be at greater risk for a number of chronic diseases.

Humulin R U-500 has been approved since 1994 for the treatment of diabetes, but a dedicated syringe did not previously exist.

Humulin R U-500 has been approved since 1994 for the treatment of diabetes, but a dedicated syringe did not previously exist.

Adherence to a plant-based diet low in animal foods found to improve overall health.

Alzheimer’s disease drugs could potentially be used to treat diabetes.

The rate of coronary heart disease declined from 2001 to 2012.

Top news of the day from across the health care landscape.

Health care delivery must change to meet the increasing demands for conservative stewardship in spending.